Form 8-K - Current report:
SEC Accession No. 0000950123-11-061495
Filing Date
2011-06-24
Accepted
2011-06-24 13:02:41
Documents
2
Period of Report
2010-06-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K g27576e8vk.htm 8-K 11210
2 EX-10.3.2 g27576exv10w3w2.htm EX-10.3.2 25599
  Complete submission text file 0000950123-11-061495.txt   37895
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 11930080
SIC: 2834 Pharmaceutical Preparations